chloroethylnorapomorphine has been researched along with phenoxybenzamine in 2 studies
| Studies (chloroethylnorapomorphine) | Trials (chloroethylnorapomorphine) | Recent Studies (post-2010) (chloroethylnorapomorphine) | Studies (phenoxybenzamine) | Trials (phenoxybenzamine) | Recent Studies (post-2010) (phenoxybenzamine) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 5,006 | 70 | 95 |
| Protein | Taxonomy | chloroethylnorapomorphine (IC50) | phenoxybenzamine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 4.9 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 2.72 | |
| Solute carrier family 22 member 3 | Homo sapiens (human) | 6.13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldessarini, RJ; Kula, NS; Law, SJ; Neumeyer, JL | 1 |
| Arana, GW; Baldessarini, RJ; Kula, NS; Law, SJ; Neumeyer, JL | 1 |
2 other study(ies) available for chloroethylnorapomorphine and phenoxybenzamine
| Article | Year |
|---|---|
Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist.
Topics: Adenylyl Cyclase Inhibitors; Animals; Aporphines; Corpus Striatum; In Vitro Techniques; Phenoxybenzamine; Rats; Receptors, Dopamine | 1980 |
Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Aporphines; Cattle; Corpus Striatum; In Vitro Techniques; Phenoxybenzamine; Rats; Receptors, Dopamine | 1980 |